Contraception and birth control Archive

Radiation therapy for prostate cancer used to involve weeks or months of treatment. Today, radiation delivery is moving toward higher doses given with fewer sessions over shorter durations. Results from a clinical trial show that the two types of therapy offer the same long-term benefits.

The experience of sexual violence may have later effects on both physical and emotional health. Being aware of these possibilities can help you identify and respond to them promptly.

There are three main treatment options for men whose prostate cancer has grown and become more likely to spread: surgical removal of the prostate, radiation to destroy the cancer cells, and hormone therapy to slow the cancer's growth. One aspect of treatment men should consider is the possibility of side effects. Understanding how common they are and their potential consequences can help men with their treatment choices.

A 2024 study suggested that women with perinatal depression, which can occur during or just after pregnancy, have significantly higher risks of developing later cardiovascular disease.

A 2024 study found that in women who had a breast cancer diagnosis in only one breast, the odds of dying from breast cancer didn't change if they had the other breast removed as a precaution.

Osteopenia and osteoporosis both involve a decline in bone density. Osteoporosis is more severe, significantly increasing the risk of fractures. Both conditions can be diagnosed with DEXA scanning, which measures calcium and other minerals in bone.

Over-the-counter menopause test kits detect levels of follicle-stimulating hormone (FSH) in a urine sample. But FSH levels can be high just before ovulation as well as when menopause is approaching, making test results ambiguous.

According to a 2024 study, the rapid, irregular heart rhythm known as atrial fibrillation is three times more prevalent than previously thought, and now affects an estimated 10.5 million Americans.

Abnormal results on a prostate-specific antigen (PSA) screening test for cancer are typically followed by a systematic biopsy. But systematic biopsies can be problematic, and researchers are seeking alternatives. A large European study provides encouraging evidence favoring a different approach that uses MRI instead of biopsy.

Men with high prostate-specific antigen (PSA) levels often get a biopsy of prostate tissue to check for cancer. The results of the biopsy are calculated to create a Gleason score, which helps doctors assess whether the cancer is low-, medium-, or high-risk. Based on that information, doctors may recommend that a man follow active surveillance (in which he monitors his PSA for changes) or begin cancer treatment.